Toralizumab Human Monoclonal Antibody
Toralizumabis a research-grade recombinant antibody targeting CD40L. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
SCD40L, Tumor necrosis factor ligand superfamily member 5, T-cell antigen Gp39, CD40L, TNFSF5, CD154, CD40-L, TNF-related activation protein, CD40 ligand, CD40LG, TRAP
UniProt
P29965
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS350011-01 0.05 mg
Anti-human Epidermal Growth Factor Monoclonal Antibody Clone 3A3-11H11
Sign In for Pricing
View Details MBS350011-02 5x 0.05 mg
Anti-human Epidermal Growth Factor Monoclonal Antibody Clone 3A3-11H11
Sign In for Pricing
View Details 
MBS1320096-01 0.02 mg (E-Coli)
Recombinant Mycobacterium leprae Uracil-DNA glycosylase (ung)
Sign In for Pricing
View Details